Search

Clometocillin

Pipemidic acid

Pipemidic acid is a quinolone antibacterial agent with activity against various gram-positive and gram-negative bacteria.

PF-06273340

Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects … of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)).

VXA-CoV2-1

This oral vaccine aims to induce immunogenicity through induction of potent serum neutralizing antibodies to the SARS-CoV-2 spike protein, induction of mucosal immune responses, and induction of T-cell … responses to both vaccine antigens of the SARS-CoV-2 nucleocapsid and spike proteins[L30498].

Diethyltryptamine

Diethyltryptamine (DET) is an orally active hallucinogenic agent and a substituted form of tryptamine.

Cinaciguat

Cinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ΜG/h, 10 ΜG/h) Given Intravenously to Patients

(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide

This compound belongs to the phenylpiperazines. These are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. This drug targets the protein S100B.

D-Tryptophan

The D-stereoisomer is occasionally found in naturally produced peptides (for example, the marine venom peptide contryphan). … It is an essential amino acid as defined by its growth effects on rats.

GC012F

GC012F is under investigation in clinical trial NCT06419166 (An Exploratory Clinical Study of GC012F Injection for Refractory gMG).

Brilacidin

Brilacidin is under investigation for the supportive care of Mucositis, Stomatitis, Mouth Diseases, and Head and Neck Neoplasms.